Understand the source comparison
How Does Adamax Compare to Other Research Peptides: Melanocortin Receptor Research Comparison
Adamax MC1R, MC4R (balanced) High. Concurrent with other effects Moderate. Dose-dependent MC4R activation Moderate. MC4R pathway 28 days refrigerated (2–8°C) Best for multi-system melanocortin research requiring simultaneous pigmentation and metabolic/sexual e
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Adamax
- MC1R, MC4R (balanced)
- High. Concurrent with other effects
- Moderate. Dose-dependent MC4R activation
- Moderate. MC4R pathway
- 28 days refrigerated (2–8°C)
- Best for multi-system melanocortin research requiring simultaneous pigmentation and metabolic/sexual endpoints
- Melanotan II (MT-2)
- MC1R (primary), MC4R (secondary)
- Very High. Dominant effect
- Low to Moderate. Secondary to pigmentation
- Low to Moderate. Inconsistent across subjects
- Optimal for isolated melanogenesis studies; unreliable for appetite or sexual function as primary endpoints
- Bremelanotide (PT-141)
- MC3R, MC4R (no MC1R)
- None. Zero pigmentation activity
- Moderate. MC4R-mediated
- High. Primary research application
- Purpose-built for sexual function research without melanogenic interference; unusable for pigmentation studies
- Alpha-MSH (endogenous)
- MC1R, MC3R, MC4R, MC5R (broad)
- Moderate. Natural ligand
- Moderate. Physiological baseline
- Low. Weak agonist potency
- Not applicable. Endogenous hormone
- Research reference standard; synthetic analogs offer greater potency and selectivity